Cholestatic hepatitis in patient treated by carbimazole: A case report | ||||
| Medical Journal of Viral Hepatitis | ||||
| Article 1, Volume 4.2, Issue 2, March 2020, Page 53-55 PDF (104.52 K) | ||||
| Document Type: Research articles | ||||
| DOI: 10.21608/mjvh.2020.80648 | ||||
 View on SCiNiTO | ||||
| Author | ||||
| Elhadidy Abdelmoneim | ||||
| Gastroetetro- and Hepatology dept., Damietta fever hospital, Egypt | ||||
| Abstract | ||||
| Antithyroid drugs are the treatment option for toxic multinodular goiter (TNG). Carbimazole is generally the drug of choice except in pregnancy where propylthiouracil is used. It is well tolerated and common side effects include allergy, gastrointestinal disorder, and rarely agranulocytosis. Hepatitis is another rare but serious complication. We reported a case of 43 years female diagnosed as hyperthyroidism, who developed cholestatic hepatitis and skin manifestation after carbimazole treatment for 2 months. She recovered completely following withdrawal of the drug and steroid therapy. | ||||
| Keywords | ||||
| Cholestasis; Hyperthyroidism and antithyroid drugs | ||||
|
Statistics Article View: 221 PDF Download: 750 |
||||
